A Randomized Prospective Trial of Conversion to Everolimus Therapy From Calcineurin Inhibitor Based Maintenance Immunosuppression in Association With Mycophenolic Acid in Liver Transplantation: Examination of Impact on Long Term Renal Function.
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2019
Price : $35 *
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Mycophenolic acid; Tacrolimus
- Indications Liver transplant rejection; Renal failure
- Focus Therapeutic Use
- 27 Aug 2019 Status changed from active, no longer recruiting to completed.
- 06 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated